Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline

Journal of Alzheimer's Disease

Volumn 20, Issue 3, 2010, Pages 855-859

  Kitagawa, Kazuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow; cerebral small vessel disease; cognitive decline; hypertension; positron emission tomography

Indexed keywords

AZELNIDIPINE; HEMOSIDERIN; LOSARTAN; VALSARTAN;

ATHEROSCLEROSIS; BASILAR ARTERY; BLOOD BRAIN BARRIER; BLOOD FLOWMETRY; BLOOD PRESSURE; BRAIN; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN PERFUSION; CAROTID ARTERY; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DOPPLER FLOWMETRY; DYSLIPIDEMIA; FOLLOW UP; HEART; HUMAN; HYPERTENSION; KIDNEY; LEUKOENCEPHALOPATHY; MIDDLE CEREBRAL ARTERY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA; REVIEW; RISK FACTOR; TARGET ORGAN; TEMPORAL LOBE; VASCULAR DISEASE; VASCULAR RESISTANCE; WHITE MATTER;

EID: 77954555494     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091324     Document Type: Review

References (40)

1. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk factor for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5, 735-741.
2. Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487-499.
3. Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metabolism 7, 476-484.
4. de la Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3, 184-190.
5. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG (2003) Circle ofWillis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Aretrioscler Thromb Vasc Biol 23, 2055-2062.
6. Davis DG, Schmitt FA,Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58, 376-388.
7. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation 115, 459-467.
8. Vermeer SE, Longstretch JrWT, Knoudstaal PJ (2007) Silent brain infarcts: a systematic review. Lancet Neurol 6, 611-619.
9. Roman GC, Erkinjuntti T, Wallin A, Pantone L, Chui HC (2002) Subcortical ischemic vascular dementia. Lancet Neurol 1, 426-436.
10. Cordonnier C, Al-Shahi Salman R, Wardlaw J (2007) Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 30, 1988-2003.
11. Henskens LH, van Oostenbrugge RJ, Kroon AA, Hofman PA, Lodder J, de Leeuw PW(2009) Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens 27, 846-853.
12. Bernick C, Kuller L, Dulberg C, Longstreth WTJr, Manolio T, Beauchamp N, Price T (2001) Cardiovascular Health Study Collaborative Research Group. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57, 1222-1229.
13. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S (1997) Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28, 1932-1939.
14. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent brain infarcts and the risk of dementia and cognitive decline.NEngl JMed 348, 1215-1222.
15. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM(2005) Cerebral smallvessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034-2041.
16. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F,Visser MC, Fazekas F, Schmidt R, O'Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T (2009) Longitudinal cognitive decline in subcortical ischemic vascular disease - the LADIS Study. Cerebrovasc Dis 27, 384-391.
17. Moorhouse P, Rockwood K (2008) Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 7, 246-255.
18. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39, 2712-2719.
19. Geroldi C, Rossi R, Calvagna C, Testa C, Bresciani L, Binetti G, Zanetti O, Frisoni GB (2006) Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry 77, 1219-1222.
20. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M (1990) Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 21, 1694-1699.
21. Nakane H, Ibayashi S, Fujii K, Sadoshioma S, Irie K, Kitazono T, Fujishima M(1998) Cerebral blood flow and metabolism in patients with silent brain infarction: occult misery perfusion in the cerebral cortex. J Neurol Neurosurg Psychiatry 65, 317-321.
22. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Willimas SC, Markus HS (2002) Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59, 321-326.
23. Paulson OB, Strandgaard S, Edvinsson L (1990) Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2, 161-192.
24. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton- Tyrrell K, van der Veen FM, Meltzer CC (2005) Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 64, 1358-1365.
25. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM (2007) Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 38, 1766-1773.
26. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2008) Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 39, 349-354.
27. de la Torre JC (2008) Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis 5, 126-132.
28. RuitenbergA, den Heijer T, Bakker SL, van Swieten JC,Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 57, 789-794.
29. Kitagawa K, Oku N, Kimura Y, Yagita Y, Sakaguchi M, Hatazawa J, Sakoda S (2009) Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease. Hypertens Res 32, 816-820.
30. Liem MK, Lesnik Oberstein SA, Haan J, Boom R, Ferrari MD, Buchem MA, Grond J (2009) Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL. AJNR Am J Neuroradiol 30, 1244-1247.
31. van den Boom R, Lesnik Oberstein SA, Spilt A, Behloul F, Ferrari MD, Haan J,Westendorp RG, van Buchem MA (2003) Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab 23, 599-604.
32. Meyer JS, Konno S, Margishvili GM, Terayama Y (1998) Vasodilator responses to acetazolamide tested in subtypes of vascular dementia. J Stroke Cerebrovasc Dis 7, 323-329.
33. Matsushita K,Kuriyama Y, Nagatsuka K, Nakamura M, Sawada T, Omae T (1994) Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 23, 565-568.
34. Kimura Y, Kitagawa K, Oku N, Kajimoto K, Kato H, Tanaka M, Sakaguchi M, Hougaku H, Sakoda S, Hatazawa J (2008) Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions. Hypertens Res 31, 2147-2154.
35. Kimura Y, Kitagawa K, Oku N, Kajimoto K, Kato H, Tanaka M, Sakaguchi M, Hougaku H, Sakoda S, Hatazawa J (2010) Blood pressure lowering with varsartan is associated with maintenance of cerebral blood flow and cerebral perfusion reserve in hypertensive patients with cerebral small vessel disease. J Stroke Cerebrovasc Dis 19, 85-91
36. Hatazawa J, Shimosegawa E, Osaki Y, Ibaraki M, Oku N, Hasegawa S, Nagata K, Hirata Y, Miura Y (2004) Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. Stroke 35, 2117-2122.
37. Oku N, Kitagawa K, Imaizumi M, Takasawa M, Piao R, Kimura Y, Kajimoto K, Matsumoto M, Hori M, Hatazawa J (2005) Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertens Res 28, 43-49
38. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Gired X, Laks T, Lilov E, Moisseyev V, Tuomiletho J, Vanhanen H, Webster J, Yodfat Y, Fagard R (1998) Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351.
39. McGuinness B, Todd S, Passmore P, Bullock R (2006) The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2, CD004034.
40. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C,Waldman A,Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C, HYVET investigators (2008) Incident dementia and blood pressure lowering in the Hypertension in theVery Elderly Trial cognitive function assessment (HYVETCOG): a double-blind, placebo controlled trial. Lancet Neurol 7, 683-689.